LABORATORY CORPORATION OF AMERICA - COVID-19 LAB TESTING
Key Details
Description
COVID-19 LAB TESTING
Context & Analysis
On Feb 5, 2026, Department of Health and Human Services obligated $32,283,750 to LABORATORY CORPORATION OF AMERICA for covid-19 lab testing. The award is classified under NAICS 621511 — MEDICAL LABORATORIES and issued as a firm fixed price contract. Competition extent: full and open competition with 23 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BURLINGTON, NC. This award is one of several similar procurements from Department of Health and Human Services under NAICS 621511 — related awards are listed below.
Contractor Information
Similar Awards
ASSESSMENT FOR COVID-19 AMONG FIRST RESPONDERS CONTRACTING OFFICER: FOR ANY QUESTIONS REGARDING THIS CONTRACT PLEASE CONTACT THE CONTRACTING OFFICER, DAVID MORGAN AT 301.492.4655 OR DAVID.MORGAN@PSC.HHS.GOV. CONTRACTING OFFICER'S REPRESEN
QUEST DIAGNOSTICS INCORPORATED
$7.4M
REFERENCE LAB AND PATHOLOGY SERVICES
QUEST DIAGNOSTICS INCORPORATED
$3.2M
EXERCISE FOURTH OPTION PERIOD NAIHS-REFERRAL CLINICAL LAB TESTING SERVICES
LABORATORY CORPORATION OF AMERICA
$2.4M
NAIHS-REFERRAL CLINICAL LAB TESTING SERVICES FOR THE KAYENTA HEALTH CENTER.
LABORATORY CORPORATION OF AMERICA
$1.8M
LAB SUPPLIES INCLUSIVE OF TESTING SUPPLIES USING CEPHEID GENEXPERT ANALYZER INCLUDING MICROBIOLOGY SUPPLIES, REAGENT KITS AND COVID-19 TEST KITS, ORDER "AS NEEDED".
CEPHEID
$1.5M
Stay Updated
Get notified about new opportunities matching your interests.